Income Statement
Balance Sheet
Cash Flow
| Line Item | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 128.2M | -85.0M | 39.3M | 32.0M | 51.3M |
| Operating Revenue | 128.2M | -85.0M | 39.3M | 32.0M | 51.3M |
| Selling General And Administration | -- | -- | -- | -- | -- |
| General And Administrative Expense | -- | -- | -- | -- | -- |
| Operating Expense | 7.6M | -581,000 | 15.4M | 11.3M | 5.0M |
| Interest Expense | 1.0M | 3.2M | 7.2M | -- | -10.4M |
| Interest Income | 47.2M | -22.9M | 7.7M | 36.3M | 16.3M |
| Net Interest Income | 46.1M | -26.1M | 483,000 | 9.6M | 16.3M |
| Pretax Income | 120.6M | -84.4M | 23.9M | 20.8M | 46.3M |
| Tax Provision | 15.5M | -7.7M | 2.5M | 65,000 | 7.9M |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | 105.1M | -76.8M | 21.3M | 20.7M | 38.5M |
| Net Income From Continuing Operation Net Minority Interest | 105.1M | -76.8M | 21.3M | 20.7M | 38.5M |
| Net Income Including Noncontrolling Interests | 105.1M | -76.8M | 21.3M | 20.7M | 38.5M |
| Net Income Common Stockholders | 105.1M | -76.8M | 21.3M | 20.7M | 38.5M |
| Net Income | 105.1M | -76.8M | 21.3M | 20.7M | 38.5M |
| Reconciled Depreciation | 397,000 | 379,000 | 377,000 | 354,000 | 366,000 |
| Basic EPS | 7.65 | -5.43 | 1.51 | -- | 2.70 |
| Diluted EPS | 7.65 | -5.43 | 1.51 | -- | 2.70 |
| Basic Average Shares | 13.7M | 14.1M | 14.1M | -- | 14.2M |
| Diluted Average Shares | 13.7M | 14.1M | 14.1M | -- | 14.2M |
| Tax Rate For Calcs | 0.13 | 0.09 | 0.11 | 0.00 | 0.17 |
| Normalized Income | 105.1M | -76.8M | 21.3M | 20.7M | 38.5M |
| Diluted NI Availto Com Stockholders | 105.1M | -76.8M | 21.3M | 20.7M | 38.5M |
| Net Income Continuous Operations | 105.1M | -76.8M | 21.3M | 20.7M | 38.5M |
| Line Item | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 199.1M | 118.5M | 165.0M | 177.0M | 179.3M |
| Cash Equivalents | 12.7M | 3.3M | 3.3M | 3.7M | 1.5M |
| Cash Financial | 186.4M | 115.1M | 161.7M | 173.3M | 177.8M |
| Receivables | 101.3M | 124.5M | 115.0M | 121.7M | 113.5M |
| Gross PPE | 20.1M | 20.1M | 20.1M | 20.1M | 13.8M |
| Accumulated Depreciation | -9.5M | -9.1M | -8.7M | -8.4M | -8.0M |
| Net PPE | 10.6M | 11.0M | 11.3M | 11.7M | 5.8M |
| Investments And Advances | 1.1B | 1.0B | 1.1B | 1.1B | 1.1B |
| Long Term Equity Investment | 44.1M | 47.4M | 47.9M | 48.5M | 48.8M |
| Total Assets | 1.4B | 1.3B | 1.4B | 1.4B | 1.4B |
| Accounts Payable | 10.5M | 20.7M | 28.8M | 12.7M | 14.9M |
| Payables | 11.0M | 20.7M | 28.8M | 15.2M | 14.9M |
| Total Liabilities Net Minority Interest | 151.2M | 156.2M | 187.4M | 177.8M | 174.3M |
| Common Stock | 73.4M | 73.8M | 76.0M | 76.0M | 76.3M |
| Capital Stock | 73.4M | 73.8M | 76.0M | 76.0M | 76.3M |
| Retained Earnings | 1.2B | 1.1B | 1.2B | 1.2B | 1.2B |
| Common Stock Equity | 1.3B | 1.2B | 1.3B | 1.3B | 1.2B |
| Stockholders Equity | 1.3B | 1.2B | 1.3B | 1.3B | 1.2B |
| Total Equity Gross Minority Interest | 1.3B | 1.2B | 1.3B | 1.3B | 1.2B |
| Net Tangible Assets | 1.3B | 1.2B | 1.3B | 1.3B | 1.2B |
| Tangible Book Value | 1.3B | 1.2B | 1.3B | 1.3B | 1.2B |
| Share Issued | 13.7M | 13.8M | 14.2M | 14.2M | 14.2M |
| Ordinary Shares Number | 13.7M | 13.8M | 14.2M | 14.2M | 14.2M |
| Available For Sale Securities | 70.3M | 93.6M | 103.4M | 82.0M | 56.0M |
| Cash Cash Equivalents And Federal Funds Sold | 199.1M | 118.5M | 165.0M | 177.0M | 179.3M |
| Derivative Product Liabilities | 0.00 | 7.7M | 0.00 | 18.1M | 18.2M |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 975.1M | 907.3M | 994.2M | 979.6M | 945.0M |
| Investmentin Financial Assets | 1.0B | 1.0B | 1.1B | 1.1B | 1.1B |
| Taxes Receivable | 4.8M | 8.4M | 9.5M | 8.9M | 7.3M |
| Total Tax Payable | 464,000 | 0.00 | 0.00 | 2.5M | -- |
| Trading Securities | -- | -- | -- | -- | 52.9M |
| Line Item | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | 84.9M | -5.3M | -11.4M | 1.4M | 5.5M |
| Depreciation And Amortization | 397,000 | 379,000 | 377,000 | 354,000 | 366,000 |
| Change In Working Capital | 5.0M | -13.5M | -173,000 | -13.2M | -1.4M |
| Change In Receivables | 12.3M | -8.6M | -2.9M | -- | -2.4M |
| Change In Payable | -9.7M | 4.3M | 1.1M | -- | -602,000 |
| Change In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 8.6M | 0.00 |
| Other Non Cash Items | 13.9M | -13.0M | 10.1M | 27.8M | -37.6M |
| Capital Expenditure | -- | -- | -- | -232,000 | -105,000 |
| Purchase Of PPE | 0.00 | 0.00 | 0.00 | -232,000 | -105,000 |
| Net PPE Purchase And Sale | 0.00 | 0.00 | 0.00 | -232,000 | -105,000 |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | -232,000 | -105,000 |
| Repurchase Of Capital Stock | -4.3M | -28.8M | -560,000 | -3.5M | -979,000 |
| Net Common Stock Issuance | -4.3M | -28.8M | -560,000 | -3.5M | -979,000 |
| Common Stock Dividend Paid | 0.00 | -12.5M | -- | 0.00 | 0.00 |
| Common Stock Payments | -4.3M | -28.8M | -560,000 | -3.5M | -979,000 |
| Financing Cash Flow | -4.3M | -41.3M | -560,000 | -3.5M | -979,000 |
| Changes In Cash | 80.6M | -46.6M | -12.0M | -2.3M | 4.5M |
| Beginning Cash Position | 118.5M | 165.0M | 177.0M | 179.3M | 174.8M |
| End Cash Position | 199.1M | 118.5M | 165.0M | 177.0M | 179.3M |
| Free Cash Flow | 84.9M | -5.3M | -11.4M | 1.2M | 5.4M |
| Cash Dividends Paid | 0.00 | -12.5M | -- | 0.00 | 0.00 |
| Change In Accrued Expense | 2.4M | -9.2M | 1.6M | -- | 1.6M |
| Depreciation | 397,000 | 379,000 | 377,000 | 354,000 | 366,000 |
| Dividend Received Cfo | 37.8M | -- | -- | 291,000 | 8.1M |
| Gain Loss On Investment Securities | -74.3M | 102.5M | -52.3M | -9.2M | 442,000 |
| Net Income From Continuing Operations | 105.1M | -76.8M | 21.3M | 20.7M | 38.5M |
| Net Other Financing Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |